de Oliveira Costa J, Lin J, Milder TY, Greenfield JR, et al. Geographic variation in sodium-glucose cotransporter 2 inhibitor and glucagon-like peptide-1 receptor agonist use in people with type 2 diabetes in New South Wales, Australia. Diabetes Obes Metab 2024 Apr 15. doi: 10.1111/dom.15597.
PMID: 38618983